Announcement on Initially Repurchasing Shares through Call Auction
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Initially Repurchasing Shares through Call Auction
Filed with SSE · · 2 pages · Chinese
Release
Jiangsu Kanion Pharmaceutical Co. Ltd. on 6ix
Earlier from Jiangsu Kanion Pharmaceutical
- Announcement on Inclusion of Certain Pharmaceutical Products of the Company in the National Essential Medicines List
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Cancellation of Repurchased Shares and Notification to Creditors
- Announcement on Shareholding of Top 10 Shareholders and Top 10 Holders of Shares Without Sales Limit
- Notice on Convening the 2025 Annual General Meeting
Later from Jiangsu Kanion Pharmaceutical
- Announcement on Receipt of the Clinical Trial Approval Notice for Qihuang Zhengqi Granules
- Semi-annual Report for 2026
- (600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction
- (600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Departure of Senior Executive
- (600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Receipt of the Clinical Trial Approval Notice for Shiwei Anchang Granules
Follow Jiangsu Kanion Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Kanion Pharmaceutical